en
Scientific article
Open access
English

Seroprevalence of anti-SARS-CoV-2 IgG antibodies, risk factors for infection and associated symptoms in Geneva, Switzerland: a population-based study

Published inScandinavian journal of public health, 140349482110480
First online date2021-10-19
Abstract

Aims: To assess SARS-CoV-2 seroprevalence over the first epidemic wave in the canton of Geneva, Switzerland, as well as risk factors for infection and symptoms associated with IgG seropositivity. Methods: Between April and June 2020, former participants of a representative survey of the 20–74-year-old population of canton Geneva were invited to participate in the study, along with household members aged over 5 years. Blood samples were tested for anti-SARS-CoV-2 immunoglobulin G. Questionnaires were self-administered. We estimated seroprevalence with a Bayesian model accounting for test performance and sampling design. Results: We included 8344 participants, with an overall adjusted seroprevalence of 7.8% (95% credible interval 6.8–8.9). Seroprevalence was highest among 18–49 year-olds (9.5%), and lowest in 5–9-year-old children (4.3%) and individuals >65 years (4.7-5.4%). Odds of seropositivity were significantly reduced for female retirees and unemployed men compared to employed individuals, and smokers compared to non-smokers. We found no significant association between occupation, level of education, neighborhood income and the risk of being seropositive. The symptom most strongly associated with seropositivity was anosmia/dysgeusia. Conclusions: Anti-SARS-CoV-2 population seroprevalence remained low after the first wave in Geneva. Socioeconomic factors were not associated with seropositivity in this sample. The elderly, young children and smokers were less frequently seropositive, although it is not clear how biology and behaviours shape these differences.

eng
Keywords
  • COVID-19
  • SARS-CoV-2
  • Population-based survey
  • Seroprevalence
  • Socioeconomic risk factors
Citation (ISO format)
RICHARD, Aude et al. Seroprevalence of anti-SARS-CoV-2 IgG antibodies, risk factors for infection and associated symptoms in Geneva, Switzerland: a population-based study. In: Scandinavian journal of public health, 2021, p. 140349482110480. doi: 10.1177/14034948211048050
Main files (1)
Article (Published version)
Secondary files (1)
Identifiers
ISSN of the journal1403-4948
172views
53downloads

Technical informations

Creation11/17/2021 3:20:00 PM
First validation11/17/2021 3:20:00 PM
Update time03/16/2023 2:15:40 AM
Status update03/16/2023 2:15:38 AM
Last indexation01/29/2024 11:13:33 PM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack